Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
3 Best Growth Stocks to Own for the Next 10 Years
08:17am, Wednesday, 28'th Aug 2024
During times of market volatility, it's always good for long-term investors to take a breath and zoom out. That doesn't mean getting out of the markets as fast as possible.
My Dividend Stock Portfolio: New July Dividend Record - 101 Holdings With 24 Buys
08:10am, Wednesday, 28'th Aug 2024
Investment activity in July focused on Business Development Companies, with $2,000 added to the market. Adjusted dividend income in July of $709, up 19% Y/Y and down 4% sequentially. Main picks includ
AbbVie: I'm Up 149% And Holding This Dividend Aristocrat Now
07:30am, Wednesday, 28'th Aug 2024
AbbVie is one of my biggest winners and a top 10 holding in my portfolio. The company's increasing contributions from Skyrizi and Rinvoq pushed net revenue higher in Q2. AbbVie maintains its A- credit
Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock
06:32am, Wednesday, 28'th Aug 2024
Eli Lilly is exploring whether its newest hit drug could be used to treat psoriasis. AbbVie's newest hit drugs already treat psoriasis, among other conditions.
Why AbbVie Remains One Of My Favorite Dividend Growers
04:40pm, Tuesday, 27'th Aug 2024
AbbVie has shown strong growth, especially in immunology and oncology, with Skyrizi and Rinvoq driving impressive sales and long-term growth potential. Despite Humira's patent loss, AbbVie has managed
2 Stocks to Buy Now Before a Stock Market Crash
10:19am, Tuesday, 27'th Aug 2024
A recession is looming. Despite the S&P 500 nearing its all-time high, the yield curve inverted and the
AbbVie Awards Scholarships to 45 U.S. Students Living With Chronic Immune-Mediated Diseases
08:15am, Tuesday, 27'th Aug 2024
More than 400 undergraduate and graduate students in the U.S. have benefited from the AbbVie Immunology Scholarship since its inception in 2016 NORTH CHICAGO, Ill. , Aug. 27, 2024 /PRNewswire/ -- Abb
SkinMedica® Revolutionizes Skin Hydration with the Introduction of HA5® Hydra Collagen Replenish + Restore Hydrator
08:05am, Tuesday, 27'th Aug 2024
SkinMedica®, by the makers of BOTOX® Cosmetic (onabotulinumtoxinA) launches the first and only product to use a proprietary complex of five forms of Hyaluronic Acid (HA) and Hydra Collagen, plus Ad
Cigna to remove AbbVie's Humira from some drug reimbursement lists next year
12:36pm, Monday, 26'th Aug 2024
Cigna said on Monday it will remove AbbVie's blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey biosimilar vers
3 Unstoppable Dividend Stocks to Buy Right Now
06:30pm, Sunday, 25'th Aug 2024
Abbott Laboratories is a Dividend King with a diverse business. Amgen offers a high dividend yield plus a track record of innovation.
Is Merck Stock A Better Pick Over AbbVie?
05:00am, Wednesday, 21'st Aug 2024
We believe that the pharmaceuticals giant Merck (NYSE: MRK) is currently a better pick over its peer, AbbVie stock. MRK stock trades at 14x forward earnings, versus 20x for ABBV.
AbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use
10:46am, Tuesday, 20'th Aug 2024
AbbVie's (ABBV) Tepkinly gets conditional approval in the EU to treat third-line patients with relapsed or refractory follicular lymphoma as a second indication.
TEPKINLY (epcoritamab) is the first and only subcutaneous bispecific antibody conditionally approved as a monotherapy in the European Union to treat both relapsed or refractory (R/R) follicular lymph
3 High-Yield Stocks to Buy Now That Have Increased Their Dividends for 25 Years or More
05:50am, Sunday, 18'th Aug 2024
AbbVie is a Dividend King that's poised for future growth. Enbridge offers an ultra-high dividend yield and is expanding into more areas of the energy sector.
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
03:19am, Sunday, 18'th Aug 2024
Keytruda, Humira, and Ozempic generated a combined $53 billion in sales last year. The companies that make these drugs generate a lot of their sales from them.
